TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bio-Works Technologies AB
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
25,465
|
43,896
|
41,320 |
| Financial expenses |
9
|
3
|
23 |
| Earnings before taxes |
-37,281
|
-54,734
|
-44,695 |
| EBITDA |
-37,482
|
-55,737
|
-45,621 |
| Total assets |
52,497
|
62,152
|
91,613 |
| Current assets |
50,679
|
59,663
|
89,180 |
| Current liabilities |
7,913
|
18,119
|
23,921 |
| Equity capital |
44,584
|
44,033
|
67,692 |
| - share capital |
7,796
|
3,898
|
3,518 |
| Employees (average) |
33
|
39
|
43 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
84.9%
|
70.8%
|
73.9% |
| Turnover per employee |
772
|
1,126
|
961 |
| Profit as a percentage of turnover |
-146.4%
|
-124.7%
|
-108.2% |
| Return on assets (ROA) |
-71.0%
|
-88.1%
|
-48.8% |
| Current ratio |
640.5%
|
329.3%
|
372.8% |
| Return on equity (ROE) |
-83.6%
|
-124.3%
|
-66.0% |
| Change turnover |
-18,431
|
2,576
|
19,410 |
| Change turnover % |
-42%
|
6%
|
89% |
| Chg. No. of employees |
-6
|
-4
|
11 |
| Chg. No. of employees % |
-15%
|
-9%
|
34% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.